Lilly Gets Conditional Approval of Duloxetine for Urinary Incontinence
Wednesday, 03 September 2003
NEW YORK (Reuters) - Eli Lilly and Co. said on Wednesday it received conditional regulatory approval for its treatment for stress urinary incontinence, casting some doubt on when the same drug, Cymbalta (duloxetine), might get clearance for depression.
read more
|
Botox Relieves Voiding Dysfunction Due to Benign Prostatic Hypertrophy
Tuesday, 26 August 2003
NEW YORK (Reuters Health) - Injection of botulinum toxin (Botox) into the prostate appears to be a safe and effective treatment for voiding dysfunction due to benign prostatic hyperplasia (BPH), Italian investigators report.
read more
|
Antimuscarinic Treatment in Parkinsonism Increases Alzheimer Pathology
Wednesday, 30 July 2003
NEW YORK (Reuters Health) - The prolonged use of antimuscarinic drugs in subjects with Parkinson's disease appears to accelerate beta-amyloidosis and neurofibrillary tangle formation, according to autopsy findings.
read more
|
Sanofi Prostate Drug Gets U.S. Approval
Monday, 16 June 2003
NEW YORK, June 16 (Reuters) - French drug maker Sanofi-Synthelabo said on Monday it had received approval from U.S. drug regulators for its prostate drug alfuzosin.
read more
|
No Major Heart Risk from Viagra Rival Levitra-US Panel
Thursday, 29 May 2003
SILVER SPRING, Md., May 29 (Reuters) - A drug aiming to become the first U.S. competitor to Pfizer Inc.'s (nyse: PFE - news - people) impotence pill Viagra is not associated with a certain type of heart risk, a U.S. advisory panel said Thursday.
read more
|
Scotland Rejects Novartis' Elidel, Backs Crestor and Cialis
Friday, 16 May 2003
The Scottish Medicines Consortium (SMC) has advised that Novartis's eczema cream Elidel (pimecrolimus) should not be prescribed by the National Health Service doctors in Scotland.
read more
|
Increasing Oxybutynin dose Improves Overactive Bladder Control
Friday, 04 April 2003
WASHINGTON, DC (Reuters Health) - Applying more oxybutynin patches increases the plasma concentration and improves overactive bladder control, according to research presented at the 2003 Annual Meeting of the Society for Clinical Pharmacology and Therapeutics here.
read more
|
Leptin Influences Cellular Differentiation and Progression in Prostate Cancer
Thursday, 27 March 2003
NEW YORK (Reuters Health) - Leptin may play a key role in the development and progression of prostate cancer through testosterone and factors related to obesity, according to a cross-sectional study reported by a Turkish team in the April issue of The Journal of Urology.
read more
|
Incontinence Repair Using Freeze-dried Donor Fascia a Disaster
Friday, 18 October 2002
SAN FRANCISCO (Reuters Health) - Follow-up of patients who received freeze-dried, irradiated donor fascia in two types of urogynecologic repairs to correct incontinence shows unacceptable failure rates, according to results reported here this week at the 23rd annual meeting of the American Urogynecologic Society.
read more
|
Instances of Acute Urinary Retention Seen with Use of COX-2 Inhibitors
Thursday, 19 September 2002
NEW YORK (Reuters Health) - Three case reports suggest that use of cyclooxygenase-2 (COX-2) inhibitors may cause acute urinary retention.
read more
|
BPH & Male LUTS 
